Marco L Davila

33PUBLICATIONS
199CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Feb 02, 2026
Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models.

Mackenzie M Lieberman, Jason H Tong, Nkechi U Odukwe

|Jul 29, 2025
Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing.

Xiaoqing Yu, Michael D Jain, Meghan A Menges

|Jun 18, 2025
Calibrating Chimeric Antigen Receptor (CAR) Signaling to Improve CAR T-Cell Therapies.

Cooper J Sailer, Chelsea E Peterson, Marco L Davila

|May 07, 2025
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy.

Sepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem

Pageof 6